Acer Therapeutics Inc.·4

Oct 6, 4:10 PM ET

Schelling Chris 4

4 · Acer Therapeutics Inc. · Filed Oct 6, 2017

Insider Transaction Report

Form 4
Period: 2017-10-04
Schelling Chris
DirectorPresident and CEO
Transactions
  • Award

    Employee Stock Option (right to buy)

    2017-10-04+46,00046,000 total
    Exercise: $15.34Exp: 2027-10-04Common Stock (46,000 underlying)
Footnotes (1)
  • [F1]The option vests and becomes exercisable over four years as follows: 25% of the shares vest on October 4, 2018, and 1/16th of the shares vest each quarter thereafter for the remaining three years.

Documents

1 file
  • 4
    section16.xmlPrimary

    FORM 4